Though the presence of coexisting hepatobiliary diseases in the majority of patients and cholestasis phenomena may have contributed to the comparably high number of TIRC7+ immune cells in non-neoplastic bile ducts, the remarkable difference to CCA tissue indicates a state of increased immunorecognition as part of the host antitumor immune response. Here, TCIRG1 is linked to cholangiocarcinoma.